Clinical Trials Browser

Not yet recruiting × Thyroid Carcinoma, Anaplastic × 90 days × Clear all

NCT07470489 2026-04-16

Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer

Phase 2 Not yet recruiting

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT07485569 2026-04-15

REPOTHYROID-II

Phase 1 Not yet recruiting

EndocrineHead & Neck

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic